DAWNA C. RINETTI

• Lead Takeda’s largest Corporate Account vertical, establishing enterprise customer strategy across the organization’s most strategically significant GPO, PBM, health plan, and IDN partnerships while balancing commercial growth, patient access, affordability, and long-term portfolio value.
• Oversee a $2 billion portfolio representing 165 million covered lives, directing enterprise partnerships with Ascent, Express Scripts/Evernorth, Cigna, Synergie, Prime Therapeutics, Humana, and other nationally significant healthcare organizations.
• Provide strategic leadership for the National and Regional Corporate Accounts organization, leading one National Director and three Regional Account Directors responsible for relationships across 18 states.
• Influenced executive decisions by translating customer priorities, healthcare policy, competitive intelligence, and market trends into commercialization, pricing, reimbursement, contracting, and portfolio strategies that enhanced Takeda’s competitive position.
• Lead enterprise customer strategy across Takeda’s most strategically significant healthcare organizations, aligning commercial priorities with evolving payer, PBM, GPO, and health plan business models.
• Shape executive commercialization, pricing, reimbursement, and contracting decisions by integrating customer insights into enterprise planning, ensuring business strategies remain aligned with market dynamics.
• Lead executive negotiations involving complex national agreements, balancing customer objectives with sustainable commercial growth, patient access, and long-term portfolio value.
• Built and led high-performing leadership organization by coaching senior leaders, strengthening organizational capability, developing future talent, and fostering culture of accountability, collaboration, innovation, and strategic execution.
• Designed Takeda’s first enterprise volume-based contracting framework, creating an innovative commercial model later expanded across additional strategic customer partnerships.
• Negotiated Takeda’s first value-based reimbursement agreement supporting the Rare Disease portfolio and advancing innovative patient access strategies.
• Led enterprise evaluation of transparent PBM and reimbursement models, partnering with executive leadership to assess commercial, legal, operational, financial, and strategic implications while shaping long-term organizational direction.
• Accelerated commercialization and market readiness for multiple specialty product launches through integrated customer strategies, executive engagement, and cross-functional leadership.
• Founded the Managed Markets & Specialty Pharmacy Innovation Lab, introducing scalable business processes, governance enhancements, and innovative tools that improved enterprise collaboration and execution.
• Appointed to Patient & Market Access Senior Leadership Team Advisory Board and recognized as Takeda Values Ambassador for leadership, organizational influence, and commitment to culture.

• Led enterprise customer strategy for Takeda’s largest national healthcare organizations, aligning customer needs with organizational goals.
• Directed enterprise strategy for national PBMs and health plans, partnering with executive leadership to shape commercialization, pricing, reimbursement, contracting, and portfolio strategies across Takeda’s specialty pharmaceutical portfolio.
• Developed executive business cases supporting enterprise pricing, contracting, reimbursement, and commercialization decisions.
• Influenced portfolio strategy by integrating customer insights, competitive intelligence, and healthcare policy analysis to adapt to evolving reimbursement trends.
• Strengthened executive partnerships to enhance strategic alignment and improve patient access across healthcare networks.
• Promoted to Senior Director in recognition of strategic leadership, executive influence, and sustained commercial performance.

Selected to provide second-line leadership for a regional commercial organization spanning approximately 80 field leaders and sales professionals during a period of significant organizational transformation.

• Elevated regional performance from #8 to #4 nationally through targeted strategies and team engagement.
• Directed regional business planning and execution, ensuring operational alignment amid organizational change.
• Enhanced leadership capabilities through executive coaching, talent development, and succession planning initiatives.

• Led strategic payer relationships across an eight-state region spanning Commercial, Medicare, and Medicaid markets while developing market access, reimbursement, and commercialization strategies.
• Secured 24 formulary access wins through innovative contracting and non-contracting strategies.
• Served as Corporate Account Liaison for UnitedHealthcare, enhancing collaboration among commercial teams to align strategies.
• Developed integrated commercialization and launch strategies with Sales, Marketing, Medical Affairs, HEOR, and Contracting & Pricing to optimize market entry.
• Promoted to Corporate Accounts for demonstrated strategic leadership and significant contributions to commercial performance.

• Led specialty sales organization to achieve commercial execution across Southern California, driving market growth.
• Executed product launches and managed care pull-through initiatives, aligning regional strategy with commercial goals.
• Recruited and coached top talent, enhancing organizational performance through targeted development initiatives.
• Earned the Cresset Gold Award and Maximum Impact Award for leadership excellence and business results.